Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells (vol 10, e004479corr1, 2022)

被引：1
|
作者：
Martin-Otal, C. [1 ]
Lasarte-Cia, A.
Serrano, D.
机构：
[1] Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷 / 09期
关键词：
D O I：
10.1136/jitc-2021-004479corr1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 49 条
  • [31] A highly-specific fully-human antibody and CAR-T cells targeting CD66e/ CEACAM5 are cytotoxic for CD66e-expressing cancer cells in vitro and in vivo
    Baek, Du-San
    Kim, Ye-Jin
    Vergara, Sandra
    Conard, Alex
    Adams, Cynthia
    Calero, Guillermo
    Ishima, Rieko
    Mellors, John W.
    Dimitrov, Dimiter S.
    CANCER LETTERS, 2022, 525 : 97 - 107
  • [32] Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutation (vol 15, 109, 2022)
    Elnaggar, Muhammad
    Agte, Sarita
    Restrepo, Paula
    Ram, Meghana
    Melnekoff, David
    Adamopoulos, Christos
    Stevens, Mark M.
    Kappes, Katerina
    Leshchenko, Violetta
    Verina, Daniel
    Jagannath, Sundar
    Poulikakos, Poulikos I.
    Parekh, Samir
    Lagana, Alessandro
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2023, 16 (01)
  • [33] Expressing IL-15/IL-18 and CXCR2 improve infiltration and survival of EGFRvIII-targeting CAR-T cells in breast cancer (vol 212, 115536, 2023)
    Sun, Ruixin
    Liu, Yifan
    Wu, Chuanlong
    Zhou, Min
    Luo, Hong
    Du, Guoxiu
    Liu, Zhengyang
    Sun, Yansha
    Dong, Yiwei
    Su, Jingwen
    Fan, Mingliang
    Shi, Bizhi
    Jiang, Hua
    Li, Zonghai
    BIOCHEMICAL PHARMACOLOGY, 2023, 214
  • [34] Ligand-based, piggyBac-engineered CAR-T cells targeting EGFR are safe and effective against non-small cell lung cancers (vol 31, pg 1, 2023)
    Chinsuwan, Thanyavi
    Hirabayashi, Koichi
    Mishima, Shuji
    Hasegawa, Aiko
    Tanaka, Miyuki
    Mochizuki, Hidemi
    Shimoi, Akihito
    Murakami, Takashi
    Yagyu, Shigeki
    Shimizu, Kimihiro
    Nakazawa, Yozo
    MOLECULAR THERAPY-ONCOLYTICS, 2023, 31
  • [35] Tandem CAR-T cells targeting MUC1 and PSCA combined with anti-PD-1 antibody exhibit potent preclinical activity against non-small cell lung cancer
    Wang, Aying
    Lv, Tangfeng
    Song, Yong
    CELLULAR IMMUNOLOGY, 2023, 391
  • [36] AIC100 CAR-T cells targeting ICAM-1 are efficacious against solid tumors in xenograft mouse models of non-small cell lung cancer (NSCLC) and cervical cancer (CC)
    Birt, Alyssa
    Josiah, Serene
    Joyce, Kelsey L.
    Alla, Srinija
    Gallagher, Michael P.
    Puc, Janusz
    Hanh Nguyen
    Martin, Emily Walsh
    Gupta, Sonal
    CANCER RESEARCH, 2023, 84 (06)
  • [37] Gallic acid induces T-helper-1-like Treg cells and strengthens immune checkpoint blockade efficacy (vol 10, e004037, 2022)
    Zang, Yuansheng
    Li, Yangyang
    Li, Bin
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (10)
  • [38] TREM1/DAP12 based novel multiple chain CAR-T cells targeting DLL3 show robust anti-tumour efficacy for small cell lung cancer
    Nie, Fengqi
    Chen, Yuli
    Hu, Yanming
    Huang, Peng
    Shi, Xuefei
    Cai, Jingsheng
    Qiu, Mantang
    Wang, Enxiu
    Lu, Kaihua
    Sun, Ming
    IMMUNOLOGY, 2024, 172 (03) : 362 - 374
  • [39] Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapy (Jul, 10.1038/s41598-019-46938-7,, 2020)
    Vedvyas, Yogindra
    McCloskey, Jaclyn E.
    Yang, Yanping
    Min, Irene M.
    Fahey, Thomas J.
    Zarnegar, Rasa
    Hsu, Yen-Michael S.
    Hsu, Jing-Mei
    van Basien, Koen
    Gaudet, Ian
    Law, Ping
    Kim, Nak Joon
    von Hofe, Eric
    Jin, Moonsoo M.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [40] TEM8/ANTXR1-Specific CAR T Cells as a Targeted Therapy for Triple-Negative Breast Cancer (vol 78, pg 489, 2018)
    Byrd, T.
    Fousek, K.
    Pignata, A.
    Szot, C.
    Samaha, H.
    Seaman, S.
    CANCER RESEARCH, 2018, 78 (12) : 3403 - 3403
12345